Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Halozyme Therapeutics - 20 Year Stock Price History | HALO

Historical daily share price chart and data for Halozyme Therapeutics since 2004 adjusted for splits and dividends. The latest closing stock price for Halozyme Therapeutics as of October 03, 2024 is 60.43.
  • The all-time high Halozyme Therapeutics stock closing price was 64.42 on August 28, 2024.
  • The Halozyme Therapeutics 52-week high stock price is 65.53, which is 8.4% above the current share price.
  • The Halozyme Therapeutics 52-week low stock price is 32.83, which is 45.7% below the current share price.
  • The average Halozyme Therapeutics stock price for the last 52 weeks is 44.49.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Halozyme Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 46.5648 37.3900 64.4200 33.6800 60.4300 63.50%
2023 39.9084 55.1300 55.7000 30.2800 36.9600 -35.04%
2022 43.6028 41.0600 59.4400 31.9700 56.9000 41.51%
2021 42.2151 42.4100 51.4500 31.8200 40.2100 -5.85%
2020 26.4060 18.1000 43.6200 13.9000 42.7100 140.89%
2019 16.5376 14.8000 19.5300 13.9400 17.7300 21.19%
2018 17.9282 20.2000 21.2000 13.3300 14.6300 -27.79%
2017 14.4885 9.9900 20.8000 9.9900 20.2600 105.06%
2016 10.1175 16.6400 16.6400 7.1700 9.8800 -42.99%
2015 17.0320 9.8200 24.7500 9.8200 17.3300 79.59%
2014 10.3892 15.0100 17.5700 7.0900 9.6500 -35.62%
2013 8.5436 6.7900 15.7000 5.1100 14.9900 123.40%
2012 8.2188 9.5400 13.3500 4.3000 6.7100 -29.44%
2011 7.0963 7.9000 9.7300 5.6200 9.5100 20.08%
2010 7.2231 6.1100 9.0200 5.4000 7.9200 34.92%
2009 6.3992 5.8500 7.8900 4.1000 5.8700 4.82%
2008 5.8338 6.7800 8.2400 2.7700 5.6000 -21.24%
2007 8.7771 8.1000 10.7600 6.1000 7.1100 -11.68%
2006 2.9132 1.8800 8.2500 1.8100 8.0500 342.31%
2005 1.8457 2.0700 2.2000 1.6000 1.8200 -17.27%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $7.655B $0.829B
Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company also licenses its novel drug delivery technology, ENHANZE. Several companies including Roche, Takeda, J&J, AbbVie, Lilly, Bristol-Myers and others are using this technology for developing subcutaneous formulation of their currently marketed drugs. It also recognizes revenues from sale of drug products to its collaboration partners for development of drugs using its ENHANZE platform. The company also has one approved product in its portfolio, Hylenex recombinant as an adjuvant to facilitate subcutaneous fluid administration. Although Halozyme has one marketed product, it derives the majority of its revenues from royalties on sales of partnered drugs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $170.591B 17.07
Vertex Pharmaceuticals (VRTX) United States $117.062B 0.00
Regeneron Pharmaceuticals (REGN) United States $111.843B 26.41
Bristol Myers Squibb (BMY) United States $109.885B 39.56
Gilead Sciences (GILD) United States $104.791B 17.91
CSL (CSLLY) Australia $95.815B 0.00
GSK (GSK) United Kingdom $79.523B 9.22
Alnylam Pharmaceuticals (ALNY) United States $34.602B 0.00
Argenex SE (ARGX) Netherlands $32.469B 0.00
BioNTech SE (BNTX) Germany $28.484B 0.00
Biogen (BIIB) United States $26.915B 11.36
Moderna (MRNA) United States $23.475B 0.00
BeiGene (BGNE) Cayman Islands $22.716B 0.00
Illumina (ILMN) United States $21.722B 148.22
Genmab (GMAB) Denmark $15.483B 19.34
BioMarin Pharmaceutical (BMRN) United States $12.942B 38.29
Incyte (INCY) United States $12.912B 838.00
Vaxcyte (PCVX) United States $12.398B 0.00
Exact Sciences (EXAS) United States $12.271B 0.00
Insmed (INSM) United States $12.270B 0.00
Bio-Techne Corp (TECH) United States $11.740B 45.96
Sarepta Therapeutics (SRPT) United States $11.326B 258.17
QIAGEN (QGEN) Netherlands $9.936B 20.98
Bio-Rad Laboratories (BIO.B) United States $9.332B 30.92
Legend Biotech (LEGN) United States $8.712B 0.00
Roivant Sciences (ROIV) United Kingdom $8.290B 0.00
Ascendis Pharma (ASND) Denmark $8.211B 0.00
Repligen (RGEN) United States $7.787B 118.84
Revolution Medicines (RVMD) United States $7.706B 0.00
Intra-Cellular Therapies (ITCI) United States $7.634B 0.00
Exelixis (EXEL) United States $7.485B 23.02
Viking Therapeutics (VKTX) United States $7.103B 0.00
Nuvalent (NUVL) United States $6.707B 0.00
Cytokinetics (CYTK) United States $6.555B 0.00
Zealand Pharma (ZLDPF) Denmark $5.957B 0.00
Blueprint Medicines (BPMC) United States $5.579B 0.00
Avidity Biosciences (RNA) United States $5.166B 0.00
Krystal Biotech (KRYS) United States $5.054B 338.33
Ultragenyx Pharmaceutical (RARE) United States $4.946B 0.00
Alkermes (ALKS) Ireland $4.672B 16.40
ADMA Biologics Inc (ADMA) United States $4.561B 75.27
Biohaven (BHVN) United States $4.410B 0.00
Axsome Therapeutics (AXSM) United States $4.331B 0.00
Immunovant (IMVT) United States $4.286B 0.00
Arcellx (ACLX) United States $4.096B 0.00
Denali Therapeutics (DNLI) United States $4.040B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.819B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.477B 0.00
Apellis Pharmaceuticals (APLS) United States $3.417B 0.00
Merus (MRUS) Netherlands $3.401B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.322B 0.00
Amicus Therapeutics (FOLD) United States $3.132B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.008B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.970B 0.00
Iovance Biotherapeutics (IOVA) United States $2.731B 0.00
Guardant Health (GH) United States $2.682B 0.00
Kymera Therapeutics (KYMR) United States $2.681B 0.00
Protagonist Therapeutics (PTGX) United States $2.612B 16.92
Bavarian Nordic (BVNRY) Denmark $2.600B 14.04
Geron (GERN) United States $2.598B 0.00
Apogee Therapeutics (APGE) United States $2.558B 0.00
Twist Bioscience (TWST) United States $2.507B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.503B 0.00
Edgewise Therapeutics (EWTX) United States $2.497B 0.00
IDEAYA Biosciences (IDYA) United States $2.471B 0.00
Zai Lab (ZLAB) China $2.452B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.442B 81.78
Structure Therapeutics (GPCR) United States $2.419B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Myriad Genetics (MYGN) United States $2.400B 0.00
ImmunityBio (IBRX) United States $2.368B 0.00
SpringWorks Therapeutics (SWTX) United States $2.364B 0.00
Novavax (NVAX) United States $2.309B 0.00
Janux Therapeutics (JANX) United States $2.304B 0.00
Keros Therapeutics (KROS) United States $2.248B 0.00
Vera Therapeutics (VERA) United States $2.220B 0.00
Neumora Therapeutics (NMRA) United States $2.168B 0.00
Celldex Therapeutics (CLDX) United States $2.044B 0.00
Vericel (VCEL) United States $2.027B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.976B 17.83
Akero Therapeutics (AKRO) United States $1.920B 0.00
Beam Therapeutics (BEAM) United States $1.891B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.890B 0.00
Ligand Pharmaceuticals (LGND) United States $1.868B 31.75
Galapagos (GLPG) Belgium $1.865B 0.00
NeoGenomics (NEO) United States $1.810B 0.00
Intellia Therapeutics (NTLA) United States $1.793B 0.00
Certara (CERT) United States $1.768B 57.84
MannKind (MNKD) United States $1.765B 64.20
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.731B 0.00
Fortrea Holdings (FTRE) United States $1.710B 53.00
Arvinas (ARVN) United States $1.681B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.590B 0.00
NovoCure (NVCR) Jersey $1.573B 0.00
Belite Bio (BLTE) United States $1.558B 0.00
Viridian Therapeutics (VRDN) United States $1.526B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.526B 0.00
Disc Medicine (IRON) United States $1.491B 0.00
Dynavax Technologies (DVAX) United States $1.466B 101.73
Rocket Pharmaceuticals (RCKT) United States $1.462B 0.00
Spyre Therapeutics (SYRE) United States $1.445B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.402B 0.00
Arcus Biosciences (RCUS) United States $1.400B 0.00
Nurix Therapeutics (NRIX) United States $1.396B 0.00
Kura Oncology (KURA) United States $1.393B 0.00
Bicara Therapeutics (BCAX) $1.232B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.228B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.211B 0.00
ANI Pharmaceuticals (ANIP) United States $1.195B 16.23
Arcutis Biotherapeutics (ARQT) United States $1.189B 0.00
Praxis Precision Medicines (PRAX) United States $1.177B 0.00
Cogent Biosciences (COGT) United States $1.155B 0.00
Gyre Therapeutics (GYRE) United States $1.144B 0.00
Tyra Biosciences (TYRA) United States $1.140B 0.00
Mesoblast (MESO) Australia $1.090B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.082B 0.00
WAVE Life Sciences (WVE) Singapore $1.060B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.055B 0.00
Travere Therapeutics (TVTX) United States $1.044B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.038B 0.00
Vir Biotechnology (VIR) United States $1.002B 0.00
AnaptysBio (ANAB) United States $0.961B 0.00
Sana Biotechnology (SANA) United States $0.945B 0.00
Cullinan Therapeutics (CGEM) United States $0.933B 0.00
Prothena (PRTA) Ireland $0.904B 0.00
Applied Therapeutics (APLT) United States $0.903B 0.00
IGM Biosciences (IGMS) United States $0.884B 0.00
Immatics (IMTX) Germany $0.876B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
ArriVent BioPharma (AVBP) United States $0.860B 0.00
MiMedx (MDXG) United States $0.840B 23.83
Immunome (IMNM) United States $0.807B 0.00
Dianthus Therapeutics (DNTH) United States $0.806B 0.00
CARGO Therapeutics (CRGX) United States $0.802B 0.00
Replimune (REPL) United States $0.799B 0.00
Castle Biosciences (CSTL) United States $0.785B 0.00
MBX Biosciences (MBX) $0.780B 0.00
Liquidia Technologies (LQDA) United States $0.775B 0.00
Adaptive Biotechnologies (ADPT) United States $0.746B 0.00
Zenas BioPharma (ZBIO) $0.745B 0.00
Tango Therapeutics (TNGX) United States $0.739B 0.00
AbCellera Biologics (ABCL) Canada $0.731B 0.00
Arbutus Biopharma (ABUS) United States $0.727B 0.00
89BIO (ETNB) United States $0.704B 0.00
Erasca (ERAS) United States $0.692B 0.00
Pliant Therapeutics (PLRX) United States $0.676B 0.00
Cytek Biosciences (CTKB) United States $0.676B 0.00
Avid Bioservices (CDMO) United States $0.674B 0.00
Oric Pharmaceuticals (ORIC) United States $0.673B 0.00
Rapport Therapeutics (RAPP) United States $0.671B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.667B 0.00
CureVac (CVAC) Germany $0.663B 0.00
Olema Pharmaceuticals (OLMA) United States $0.662B 0.00
Annexon (ANNX) United States $0.656B 0.00
Abivax SA (ABVX) France $0.651B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mineralys Therapeutics (MLYS) United States $0.642B 0.00
Astria Therapeutics (ATXS) United States $0.638B 0.00
Humacyte (HUMA) United States $0.630B 0.00
Stoke Therapeutics (STOK) United States $0.622B 0.00
LENZ Therapeutics (LENZ) United States $0.618B 0.00
Entrada Therapeutics (TRDA) United States $0.612B 5.55
Y-mAbs Therapeutics (YMAB) United States $0.603B 0.00
Nuvation Bio (NUVB) United States $0.583B 0.00
Neurogene (NGNE) United States $0.577B 0.00
Terns Pharmaceuticals (TERN) United States $0.577B 0.00
Pharming Group (PHAR) Netherlands $0.574B 0.00
Scholar Rock Holding (SRRK) United States $0.566B 0.00
Revance Therapeutics (RVNC) United States $0.551B 0.00
Celcuity (CELC) United States $0.549B 0.00
Allogene Therapeutics (ALLO) United States $0.546B 0.00
Q32 Bio (QTTB) United States $0.516B 0.00
Oculis Holding AG (OCS) Switzerland $0.512B 0.00
Third Harmonic Bio (THRD) United States $0.509B 0.00
ACELYRIN, INC (SLRN) United States $0.490B 0.00
Cartesian Therapeutics (RNAC) United States $0.488B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.483B 0.00
Anavex Life Sciences (AVXL) United States $0.475B 0.00
Alumis (ALMS) United States $0.474B 0.00
Emergent Biosolutions (EBS) United States $0.473B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
CorMedix Inc (CRMD) United States $0.463B 0.00
REGENXBIO (RGNX) United States $0.462B 0.00
Contineum Therapeutics (CTNM) United States $0.454B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.451B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.448B 0.00
Tectonic Therapeutic (TECX) United States $0.437B 0.00
Aura Biosciences (AURA) United States $0.433B 0.00
Absci (ABSI) United States $0.433B 0.00
Foghorn Therapeutics (FHTX) United States $0.414B 0.00
Alector (ALEC) United States $0.411B 0.00
Prime Medicine (PRME) United States $0.409B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.396B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.394B 0.00
Northwest Biotherapeutics (NWBO) United States $0.393B 0.00
GRAIL (GRAL) United States $0.390B 0.00
MaxCyte (MXCT) United States $0.381B 0.00
Anika Therapeutics (ANIK) United States $0.374B 180.57
Artiva Biotherapeutics (ARTV) United States $0.374B 0.00
C4 Therapeutics (CCCC) United States $0.370B 0.00
Biomea Fusion (BMEA) United States $0.365B 0.00
Fate Therapeutics (FATE) United States $0.355B 0.00
ITeos Therapeutics (ITOS) United States $0.354B 0.00
Instil Bio (TIL) United States $0.340B 0.00
GH Research (GHRS) Ireland $0.340B 0.00
AC Immune (ACIU) Switzerland $0.335B 0.00
Nautilus Biotechnology (NAUT) United States $0.330B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.329B 0.00
Voyager Therapeutics (VYGR) United States $0.327B 21.39
Inozyme Pharma (INZY) United States $0.317B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.314B 0.00
XOMA Royalty (XOMA) United States $0.309B 0.00
Kamada (KMDA) Israel $0.297B 19.15
ADC Therapeutics SA (ADCT) Switzerland $0.295B 0.00
PepGen (PEPG) United States $0.293B 0.00
Urogen Pharma (URGN) United States $0.290B 0.00
Sutro Biopharma (STRO) United States $0.289B 0.00
EnGene Holdings (ENGN) Canada $0.287B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
TScan Therapeutics (TCRX) United States $0.280B 0.00
Zura Bio (ZURA) United States $0.279B 0.00
Abeona Therapeutics (ABEO) United States $0.276B 0.00
Nkarta (NKTX) United States $0.275B 0.00
Alto Neuroscience (ANRO) United States $0.275B 0.00
Ocugen (OCGN) United States $0.273B 0.00
Rezolute (RZLT) United States $0.271B 0.00
Alpha Teknova (TKNO) United States $0.270B 0.00
Design Therapeutics (DSGN) United States $0.267B 0.00
MeiraGTx Holdings (MGTX) United States $0.266B 0.00
GENFIT S.A (GNFT) France $0.265B 0.00
Editas Medicine (EDIT) United States $0.264B 0.00
ChromaDex (CDXC) United States $0.263B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.262B 0.00
Compass Therapeutics (CMPX) United States $0.261B 0.00
Opthea (OPT) Australia $0.260B 0.00
Solid Biosciences (SLDB) United States $0.259B 0.00
Mersana Therapeutics (MRSN) United States $0.248B 0.00
Prima BioMed (IMMP) Australia $0.247B 0.00
Jasper Therapeutics (JSPR) United States $0.247B 0.00
Poseida Therapeutics (PSTX) United States $0.247B 0.00
2seventy Bio (TSVT) United States $0.245B 0.00
Amarin (AMRN) Ireland $0.244B 0.00
Precigen (PGEN) United States $0.233B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.229B 0.00
Gossamer Bio (GOSS) United States $0.228B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.228B 0.00
UniQure (QURE) Netherlands $0.222B 0.00
Codexis (CDXS) United States $0.220B 0.00
Trevi Therapeutics (TRVI) United States $0.219B 0.00
ScPharmaceuticals (SCPH) United States $0.217B 0.00
Inhibrx Biosciences (INBX) United States $0.215B 0.00
Candel Therapeutics (CADL) United States $0.215B 0.00
XBiotech (XBIT) United States $0.215B 0.00
Cabaletta Bio (CABA) United States $0.211B 0.00
Black Diamond Therapeutics (BDTX) United States $0.207B 0.00
Kyverna Therapeutics (KYTX) United States $0.199B 0.00
23andMe Holding (ME) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.188B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.185B 0.00
Innate Pharma S.A (IPHA) France $0.184B 0.00
Greenwich LifeSciences (GLSI) United States $0.180B 0.00
Eton Pharmaceuticals (ETON) United States $0.179B 0.00
BioStem Technologies (BSEM) $0.169B 26.49
Molecular Partners AG (MOLN) Switzerland $0.168B 0.00
Sangamo Therapeutics (SGMO) United States $0.165B 0.00
Scilex Holding (SCLX) United States $0.164B 0.00
Caribou Biosciences (CRBU) United States $0.162B 0.00
Compugen (CGEN) Israel $0.159B 0.00
Generation Bio (GBIO) United States $0.159B 0.00
Adverum Biotechnologies (ADVM) United States $0.151B 0.00
Tenaya Therapeutics (TNYA) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.149B 0.00
Repare Therapeutics (RPTX) Canada $0.147B 0.00
Inovio Pharmaceuticals (INO) United States $0.147B 0.00
PDS Biotechnology (PDSB) United States $0.146B 0.00
Ventyx Biosciences (VTYX) United States $0.146B 0.00
Lifecore Biomedical (LFCR) United States $0.145B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Immunic (IMUX) United States $0.143B 0.00
Seres Therapeutics (MCRB) United States $0.142B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Kodiak Sciences (KOD) United States $0.137B 0.00
Vigil Neuroscience (VIGL) United States $0.135B 0.00
ATyr Pharma (ATYR) United States $0.132B 0.00
Elutia (ELUT) United States $0.130B 0.00
Akoya Biosciences (AKYA) United States $0.126B 0.00
Sagimet Biosciences (SGMT) United States $0.126B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Adherex Technologies (FENC) United States $0.124B 113.00
Puma Biotechnology (PBYI) United States $0.124B 13.26
Rani Therapeutics Holdings (RANI) United States $0.123B 0.00
Coherus BioSciences (CHRS) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Cardiff Oncology (CRDF) United States $0.118B 0.00
Adicet Bio (ACET) United States $0.117B 0.00
Nuvectis Pharma (NVCT) United States $0.115B 0.00
Invivyd (IVVD) United States $0.115B 0.00
BioAtla (BCAB) United States $0.114B 0.00
Verastem (VSTM) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
Skye Bioscience (SKYE) United States $0.109B 0.00
X4 Pharmaceuticals (XFOR) United States $0.106B 0.00
I-Mab (IMAB) China $0.106B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.104B 0.00
Benitec Biopharma (BNTC) United States $0.104B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.101B 0.00
Adagene (ADAG) China $0.101B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.099B 0.00
Agenus (AGEN) United States $0.098B 0.00
Checkpoint Therapeutics (CKPT) United States $0.098B 0.00
MediciNova (MNOV) United States $0.097B 0.00
Inventiva S.A (IVA) France $0.096B 0.00
FibroBiologics (FBLG) United States $0.093B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
ALX Oncology Holdings (ALXO) United States $0.091B 0.00
CytomX Therapeutics (CTMX) United States $0.088B 8.07
Werewolf Therapeutics (HOWL) United States $0.088B 0.00
HilleVax (HLVX) United States $0.087B 0.00
Connect Biopharma Holdings (CNTB) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Ikena Oncology (IKNA) United States $0.081B 0.00
Genelux (GNLX) United States $0.080B 0.00
CervoMed (CRVO) United States $0.080B 0.00
Ovid Therapeutics (OVID) United States $0.080B 0.00
Genenta Science S.p.A (GNTA) Italy $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
VistaGen Therapeutics (VTGN) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Aileron Therapeutics (ALRN) United States $0.075B 0.00
Renovaro (RENB) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Immuneering (IMRX) United States $0.070B 0.00
Boundless Bio (BOLD) United States $0.070B 0.00
Spero Therapeutics (SPRO) United States $0.070B 3.15
Rapt Therapeutics (RAPT) United States $0.069B 0.00
Precision BioSciences (DTIL) United States $0.069B 0.00
IO Biotech (IOBT) Denmark $0.067B 0.00
Entera Bio (ENTX) Israel $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.066B 0.00
LakeShore Biopharma (LSB) China $0.063B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Leap Therapeutics (LPTX) United States $0.063B 0.00
Omega Therapeutics (OMGA) United States $0.063B 0.00
TELA Bio (TELA) United States $0.062B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.061B 0.00
Imunon (IMNN) United States $0.061B 0.00
Kezar Life Sciences (KZR) United States $0.060B 0.00
Allakos (ALLK) United States $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
Aerovate Therapeutics (AVTE) United States $0.057B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.053B 0.00
Lexaria Bioscience (LEXX) Canada $0.052B 0.00
Syros Pharmaceuticals (SYRS) United States $0.052B 0.00
Semper Paratus Acquisition (TVGN) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Affimed (AFMD) Germany $0.050B 0.00
Intensity Therapeutics (INTS) United States $0.050B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.049B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
Vor Biopharma (VOR) $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Cue Biopharma (CUE) United States $0.040B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Bionano Genomics (BNGO) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Immix Biopharma (IMMX) United States $0.037B 0.00
Fortress Biotech (FBIO) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Atara Biotherapeutics (ATRA) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.035B 0.00
Clene (CLNN) United States $0.034B 0.00
Ocuphire Pharma (OCUP) United States $0.034B 0.00
Promis Neurosciences (PMN) Canada $0.033B 0.00
Quince Therapeutics (QNCX) United States $0.032B 0.00
Xilio Therapeutics (XLO) United States $0.032B 0.00
Ocean Biomedical (OCEA) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
Eyenovia (EYEN) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Lumos Pharma (LUMO) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
BRIACELL THERAP (BCTX) Canada $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Aligos Therapeutics (ALGS) United States $0.026B 0.00
Longeveron (LGVN) United States $0.026B 0.00
BioAffinity Technologies (BIAF) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
RenovoRx (RNXT) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Gritstone Bio (GRTS) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Orgenesis (ORGS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.019B 0.00
Biora Therapeutics (BIOR) United States $0.019B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Monopar Therapeutics (MNPR) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Apollomics (APLM) United States $0.015B 0.00
Cingulate (CING) United States $0.015B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
IN8bio (INAB) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
Cadrenal Therapeutics (CVKD) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Aptose Biosciences (APTO) Canada $0.008B 0.00
Carmell (CTCX) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
BioCardia (BCDA) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
AquaBounty Technologies (AQB) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Trevena (TRVN) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Elevai Labs (ELAB) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Bionomics (BNOX) Australia $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Ensysce Biosciences (ENSC) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00